$Atea Pharmaceuticals, Inc.(AVIR)$
AT-527
Phase 1 - March 21 (Successful)
Phase 2 - Oct 21 (Failure)
Phase 3 - Jun 22 ( Likely to be successful from the medical test history experience)
Thus to conclude, this is a good BUY for mid-long term.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
3
举报
登录后可参与评论
暂无评论